These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10339976)

  • 21. [The effectiveness and safety of topical 0.1% tacrolimus after high-risk penetrating keratoplasty].
    Li X; Zhang YN; Yin MY; Pan ZQ
    Zhonghua Yan Ke Za Zhi; 2019 Jun; 55(6):419-427. PubMed ID: 31189271
    [No Abstract]   [Full Text] [Related]  

  • 22. Cyclosporine a drug-delivery system for high-risk penetrating keratoplasty: Stabilizing the intraocular immune microenvironment.
    Zhang T; Li Z; Liu T; Li S; Gao H; Wei C; Shi W
    PLoS One; 2018; 13(5):e0196571. PubMed ID: 29734357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment with cyclosporin A, with low doses, in high-risk penetrating keratoplasties. A bi-centric study of 90 cases].
    Robert PY; Delbosc B; Preux PM; Monnot PH; Drouet M; Peyronnet P; Adenis JP
    J Fr Ophtalmol; 1997; 20(7):507-14. PubMed ID: 9499974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Penetrating limbo-keratoplasty for granular and lattice corneal dystrophy: survival of donor limbal stem cells and intermediate-term clinical results.
    Spelsberg H; Reinhard T; Henke L; Berschick P; Sundmacher R
    Ophthalmology; 2004 Aug; 111(8):1528-33. PubMed ID: 15288983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topical corticosteroids with topical cyclosporine A versus topical corticosteroids alone for immunological corneal graft rejection.
    Marques RE; Leal I; Guerra PS; Barão RC; Quintas AM; Rodrigues W
    Eur J Ophthalmol; 2022 May; 32(3):1469-1481. PubMed ID: 34231398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcome of penetrating keratoplasty in rheumatoid arthritis.
    Pleyer U; Bertelmann E; Rieck P; Hartmann C
    Ophthalmologica; 2002; 216(4):249-55. PubMed ID: 12207127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Graft rejection and failure following endothelial keratoplasty (DSAEK) and penetrating keratoplasty for secondary endothelial failure.
    Pedersen IB; Ivarsen A; Hjortdal J
    Acta Ophthalmol; 2015 Mar; 93(2):172-7. PubMed ID: 25130326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topical Cyclosporine A in the management of postkeratoplasty glaucoma and corticosteroid-induced ocular hypertension (CIOH) and the penetration of topical 0.5% cyclosporine A into the cornea and anterior chamber.
    Perry HD; Donnenfeld ED; Acheampong A; Kanellopoulos AJ; Sforza PD; D'Aversa G; Wallerstein A; Stern M
    CLAO J; 1998 Jul; 24(3):159-65. PubMed ID: 9684074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for corneal graft failure and rejection in penetrating keratoplasty.
    Inoue K; Amano S; Oshika T; Tsuru T
    Acta Ophthalmol Scand; 2001 Jun; 79(3):251-5. PubMed ID: 11401633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prolongation of corneal allograft survival in mice with a cyclosporine drug delivery system implant].
    Shi W; Xie L; Wang S
    Zhonghua Yan Ke Za Zhi; 2002 Aug; 38(8):502-5. PubMed ID: 12410993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Large-diameter penetrating keratoplasty: indications and outcomes.
    Skeens HM; Holland EJ
    Cornea; 2010 Mar; 29(3):296-301. PubMed ID: 20118782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Interim results from the prospective "Erlanger Non-high-risk Penetrating Keratoplasty Study" in 207 patients].
    Graupner M; Seitz B; Langenbucher A; Martus P; Blüthner K; Nguyen NX; Wenkel H; Küchle M
    Klin Monbl Augenheilkd; 2000 Sep; 217(3):163-70. PubMed ID: 11076347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term outcomes of penetrating keratoplasty for keratoconus with resolved corneal hydrops.
    Basu S; Reddy JC; Vaddavalli PK; Vemuganti GK; Sangwan VS
    Cornea; 2012 Jun; 31(6):615-20. PubMed ID: 22236783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of long-term corticosteroid eye drops after penetrating keratoplasty: a prospective, randomized, clinical trial.
    Shimazaki J; Iseda A; Satake Y; Shimazaki-Den S
    Ophthalmology; 2012 Apr; 119(4):668-73. PubMed ID: 22264885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of high risk corneal graft rejection using cyclosporine A (CsA) incorporated into a collagen matrix.
    Mahlberg K; Uusitalo RJ; Oksala O
    Ocul Immunol Inflamm; 1997 Jun; 5(2):101-10. PubMed ID: 9234374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term results of corneal graft survival in infants and children with peters anomaly.
    Yang LL; Lambert SR; Lynn MJ; Stulting RD
    Ophthalmology; 1999 Apr; 106(4):833-48. PubMed ID: 10201611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Local therapy of corneal allograft rejection with cyclosporine.
    Zhao JC; Jin XY
    Am J Ophthalmol; 1995 Feb; 119(2):189-94. PubMed ID: 7832225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term outcome of systemic cyclosporine treatment following penetrating keratoplasty.
    Inoue K; Kimura C; Amano S; Sato T; Fujita N; Kagaya F; Kaji Y; Tsuru T; Araie M
    Jpn J Ophthalmol; 2001; 45(4):378-82. PubMed ID: 11485770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topical administration of tacrolimus and corticosteroids in tapering doses is effective in preventing immune rejection in high-risk keratoplasty: a 5-year follow-up study.
    Qi X; Wang L; Zhang X; Liu M; Gao H
    BMC Ophthalmol; 2022 Mar; 22(1):101. PubMed ID: 35246084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic cyclosporine in high-risk keratoplasty: long-term results.
    Hill JC
    Eye (Lond); 1995; 9 ( Pt 4)():422-8. PubMed ID: 7498559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.